|EX-99 - EXHIBIT 99 - HUMAN GENOME SCIENCES INC||c05842exv99.htm|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 13, 2010
HUMAN GENOME SCIENCES,
(Exact name of registrant as specified in its charter)
|(State or other Jurisdiction of Incorporation)||(Commission File Number)||(IRS Employer Identification No.)|
14200 Shady Grove Road, Rockville, Maryland
|(Address of Principal Executive Offices)||(Zip Code)|
Registrant’s telephone number, including area code: (301) 309-8504
|(Former name or former address if changed since last report.)|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
communications pursuant to Rule 425 under the Securities Act (17 CFR
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
From time to time, we intend to present to investors our current corporate update slides. A copy of this updated slide presentation, dated September 2010, is furnished herewith as Exhibit 99.
Item 9.01. Financial Statements and Exhibits.
99 Corporate Update Presentation, dated September 2010.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HUMAN GENOME SCIENCES, INC.
|By:||/s/ James H. Davis, Ph.D.|
|Name:||James H. Davis, Ph.D.|
|Title:||Executive Vice President, General
Counsel and Secretary
Date: September 13, 2010
INDEX TO EXHIBITS
|Corporate Update Presentation, dated September 2010.|